California-based firm OpenAI is expanding access to its life sciences AI model for select government and allied partners, marking a new step forward in the use of artificial intelligence for biodefense and biological threat preparedness.
The initiative is part of the company’s newly launched biodefense program, which provides trusted organizations with access to GPT-Rosalind, a specialized AI tool designed for life sciences research.
The program is intended to support missions such as outbreak modeling, early threat detection, preparedness planning, and the development of medical countermeasures.
OpenAI said it will sponsor access for approved developers building biodefense and pandemic preparedness applications, including epidemiological modeling, screening, and early warning capabilities.
According to Axios, OpenAI has already briefed the White House and multiple federal agencies on the initiative as it expands deployment to organizations supporting public health and biodefense missions.
Early Participants Outline Biodefense Applications
Lawrence Livermore National Laboratory is examining how the model could help researchers in analyzing scientific data, identifying potential medical countermeasures, and connecting the link between simulation and laboratory testing.
Meanwhile, Johns Hopkins Applied Physics Laboratory plans to integrate GPT-Rosalind into a protein engineering platform to accelerate screening of mutant enzymes for therapeutics, countermeasure development, and emerging biothreat characterization.
The company is also extending access to the Coalition for Epidemic Preparedness Innovations in support of its “100 Days Mission” to accelerate vaccine development for epidemic and pandemic threats.
